Vera Therapeutics Inc (VERA)
Healthcare
Biotechnology
32.10 $
-2.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Vera Therapeutics Inc (VERA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -241 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -10 | -35 | -24 | -68 | -92 | -135 | -241 | |
| 0.5 | 0.3 | 0.2 | -0.8 | -4.1 | 0.1 | 0.5 | |
| 0.3 | 0.3 | 3.0 | 8.9 | 11 | 21 | 38 | |
| 0.5 | 18 | -0.7 | 8.9 | – | – | – | |
| 0.5 | 0.1 | 3.5 | 6.7 | -5.9 | 2.7 | 23 | |
| 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 1.0 | 0.6 | |
| -0.1 | 0.0 | -4.2 | -71 | -39 | -425 | 194 | |
| – | – | 49 | 2.1 | 0.0 | 0.0 | 0.0 | |
| -0.2 | 5.5 | 4.9 | 20 | 25 | 0.0 | 23 | |
| -0.1 | 85 | 54 | 102 | 134 | 607 | 309 | |
| -11 | 50 | 26 | -36 | 1.9 | 47 | 262 | |
| -10 | -35 | -24 | -68 | -92 | -136 | -242 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.